SAND, Phillip, Berthold LANGGUTH, G. HAJAK, Martin PERNA, Radovan PŘIKRYL, Hana KUČEROVÁ, Eva ČEŠKOVÁ, C. KICK, P. STOERTEBECKER and P. EICHHAMMER. Screening for Neuroligin 4 (NLGN4) truncating and transmembrane domain mutations in schizophrenia. Schizophrenia Research. 2005, vol. 85, 2-3, p. 277-278. ISSN 0920-9964.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name Screening for Neuroligin 4 (NLGN4) truncating and transmembrane domain mutations in schizophrenia
Name in Czech Neuroligin 4 a transmembránové mutace u schizofrenie
Authors SAND, Phillip (276 Germany), Berthold LANGGUTH (276 Germany), G. HAJAK (276 Germany), Martin PERNA (203 Czech Republic), Radovan PŘIKRYL (203 Czech Republic, guarantor), Hana KUČEROVÁ (203 Czech Republic), Eva ČEŠKOVÁ (203 Czech Republic), C. KICK (276 Germany), P. STOERTEBECKER (276 Germany) and P. EICHHAMMER (276 Germany).
Edition Schizophrenia Research, 2005, 0920-9964.
Other information
Original language English
Type of outcome Article in a journal
Field of Study 30000 3. Medical and Health Sciences
Country of publisher Germany
Confidentiality degree is not subject to a state or trade secret
Impact factor Impact factor: 4.231
RIV identification code RIV/00216224:14110/05:00021736
Organization unit Faculty of Medicine
UT WoS 000236492500021
Keywords in English neuroligin; schizophrenia
Tags neuroligin, schizophrenia
Tags International impact, Reviewed
Changed by Changed by: prof. PhDr. Hana Přikrylová Kučerová, Ph.D., učo 23265. Changed: 19/6/2009 10:42.
Abstract
The present findings suggest that neither of two previously described NLGNX4 truncating mutations plays a major role in schizophrenia. Systematic screening of the transmembrane domain sequence of NLGN4X and NLGN4Y confirmed that this key functional region is also highly conserved in schizophrenic subjects. Our data currently do not rule out mutations in the remaining NLGN4 sequences, spanning 140kb on the X-chromosome, and 340kb on the Y-chromosome. More detailed investigations, however, including autosomal neuroligin genes, have now equally tempered expectations of a strong neuroligin genotype-phenotype association in other neurodevelopmental disorders (Vincent et al., 2004; Ylisaukko-Oja et al., 2005). Thus the phenotypic risk ascribable to truncating NLGN4 variants is most likely limited to rare monogenetic syndromes distinct from the majority of autistic and schizophrenic typologies.
Abstract (in Czech)
Naše data ukazují na souvislost mezi mutacemi NLGNX4 a schizofrenií.
Links
MSM0021622404, plan (intention)Name: Vnitřní organizace a neurobiologické mechanismy funkčních systémů CNS
Investor: Ministry of Education, Youth and Sports of the CR, The internal organisation and neurobiological mechanisms of functional CNS systems under normal and pathological conditions.
PrintDisplayed: 1/5/2024 13:41